ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2457
-0,01%
Bitcoin
69.019,72
1,88%
Brent Oil
81,155
0,43%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Senti Biosciences Inc (SNTI)

  7. Senti Biosciences Inc (SNTI) Notícias

SNTI

Senti Biosciences (SNTI)

Senti Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNTI
DataHoraFonteTítuloCódigoCompanhia
29/05/202417:14Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SNTISenti Biosciences Inc
29/05/202417:09Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SNTISenti Biosciences Inc
29/05/202417:07Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNTISenti Biosciences Inc
17/05/202418:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SNTISenti Biosciences Inc
17/05/202418:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNTISenti Biosciences Inc
13/05/202409:15GlobeNewswire Inc.Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid LeukemiaNASDAQ:SNTISenti Biosciences Inc
09/05/202417:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNTISenti Biosciences Inc
09/05/202417:05GlobeNewswire Inc.Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate HighlightsNASDAQ:SNTISenti Biosciences Inc
30/04/202409:05GlobeNewswire Inc.Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)NASDAQ:SNTISenti Biosciences Inc
21/03/202417:05GlobeNewswire Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent HighlightsNASDAQ:SNTISenti Biosciences Inc
05/01/202418:05GlobeNewswire Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical ProgramNASDAQ:SNTISenti Biosciences Inc
22/12/202308:30GlobeNewswire Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid LeukemiaNASDAQ:SNTISenti Biosciences Inc
13/11/202318:15GlobeNewswire Inc.Senti Bio Announces Third Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
06/11/202318:05GlobeNewswire Inc.Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in ChinaNASDAQ:SNTISenti Biosciences Inc
31/10/202310:06GlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual MeetingNASDAQ:SNTISenti Biosciences Inc
27/09/202310:05GlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 MeetingNASDAQ:SNTISenti Biosciences Inc
26/09/202317:05GlobeNewswire Inc.Senti Bio to Participate in Upcoming ConferencesNASDAQ:SNTISenti Biosciences Inc
05/09/202309:30GlobeNewswire Inc.Senti Bio to Participate in Upcoming Investor ConferencesNASDAQ:SNTISenti Biosciences Inc
11/08/202309:35GlobeNewswire Inc.Senti Bio Announces Second Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
10/08/202309:35GlobeNewswire Inc.Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon PartnersNASDAQ:SNTISenti Biosciences Inc
20/05/202309:05GlobeNewswire Inc.Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual MeetingNASDAQ:SNTISenti Biosciences Inc
09/05/202317:05GlobeNewswire Inc.Senti Bio Announces First Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
02/05/202317:45GlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual MeetingNASDAQ:SNTISenti Biosciences Inc
17/04/202309:45GlobeNewswire Inc.Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR MeetingNASDAQ:SNTISenti Biosciences Inc
22/03/202318:09GlobeNewswire Inc.Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent HighlightsNASDAQ:SNTISenti Biosciences Inc
14/03/202317:35GlobeNewswire Inc.Senti Bio Announces Three Preclinical Data Presentations from Gene Circuit-Enhanced CAR-NK Cell Oncology Pipeline at Annual AACR MeetingNASDAQ:SNTISenti Biosciences Inc
03/02/202318:05GlobeNewswire Inc.Senti Biosciences Announces New Employment Inducement GrantsNASDAQ:SNTISenti Biosciences Inc
01/02/202318:05GlobeNewswire Inc.Senti Bio to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:SNTISenti Biosciences Inc
27/01/202310:00GlobeNewswire Inc.Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway GuidanceNASDAQ:SNTISenti Biosciences Inc
19/12/202209:55GlobeNewswire Inc.Senti Bio to Present at 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:SNTISenti Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNTI

Seu Histórico Recente

BMF
DIFV24J25
DIFV24J25 - 10/2024
LSE
32SS
Nat Bk Canada25
NASDAQ
FELE
Franklin Electric
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados